Table 7.
Association between BNT162b2 and other miscellaneous adverse events from large-scale controlled surveillance studies.
| Barda et al. [25] | Klein et al. [33] | Lai et al. [34] | |
|---|---|---|---|
| Appendicitis | RR: 1.4 EC: 5 per 100,000 people |
Non-sig. | - |
| Lymphadenopathy | RR: 2.43 EC: 78.4 per 100,000 people |
- | - |
| Anemia | RR: 0.79 EC: −18.7 per 100,000 people |
- | - |
| Acute kidney injury | RR: 0.44 EC: −4.6 per 100,000 people |
- | HR: 0.58 |
| Acute liver injury | - | - | |
| Pancreatitis | - | - | |
| Acute respiratory distress syndrome | - | - | HR: 0.21 |
| Neutropenia | Non-sig. | - | - |
| Lymphopenia | Non-sig. | - | - |
| Uveitis | Non-sig. | - | - |
| Arthritis | Non-sig. | - | Non-sig. |
| Kawasaki disease | - | Non-sig. | - |
| Thyroiditis | - | - | Non-sig. |
| Type 1 diabetes | - | - | Non-sig. |
| Erythema multiforme | - | - | Non-sig. |
| Chilblain | - | - | Non-sig. |
| Rhabdomyolysis | - | - | Non-sig. |
| Syncope | - | - | Non-sig. |
| Narcolepsy | - | - | Non-sig. |
Abbreviations/acronyms: EC: excess cases; HR: hazard ratio; RR: risk or relative ratio. Notes: (i) non-sig. means not statistically significant; (ii) if EC is not provided, it is not available; (iii) hyphen (-) denotes not available, that is, unexamined.